GT Biopharma Inc (GTBP) — Capital Reinvestment Ratio

Latest as of September 2014: 0.00x

GT Biopharma Inc (GTBP) has a Capital Reinvestment Ratio of 0.00x as of September 2014, meaning it reinvests 0% of its operating cash flow ($45.00K) in capital expenditures ($2.00). See GTBP net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$45.00K
USD

Capital Expenditures

$2.00
USD

Data as of

Sep 2014
Most recent filing

GT Biopharma Inc Capital Reinvestment Ratio (1987–1987)

This chart tracks GT Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Check GT Biopharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for GT Biopharma Inc (1987–1987)

Year-by-year Capital Reinvestment Ratio for GT Biopharma Inc from 1987 to 1987. For live market cap and broader valuation context, see GT Biopharma Inc market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
1987 1.00x $50.00K $50.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow